Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma. [electronic resource]
Producer: 20020111Description: 3534-40 p. digitalISSN:- 0006-4971
- Animals
- Bone Density
- Bone and Bones -- pathology
- Carrier Proteins -- analysis
- Flow Cytometry
- Gene Expression
- Glycoproteins -- administration & dosage
- Male
- Membrane Glycoproteins -- analysis
- Mice
- Mice, Inbred C57BL
- Multiple Myeloma -- chemistry
- Neoplasm Transplantation
- Osteolysis -- etiology
- Osteoprotegerin
- RANK Ligand
- RNA, Messenger -- analysis
- Receptor Activator of Nuclear Factor-kappa B
- Receptors, Cytoplasmic and Nuclear -- administration & dosage
- Receptors, Tumor Necrosis Factor
- Recombinant Proteins -- administration & dosage
- Reverse Transcriptase Polymerase Chain Reaction
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.